ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-04
DOI
10.1038/s41419-019-2054-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
- (2018) Sung-Hwan Moon et al. CELL
- The Role of Cholesterol in Cancer
- (2016) Omer F. Kuzu et al. CANCER RESEARCH
- ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma
- (2016) Lu Xu et al. TUMOR BIOLOGY
- Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation
- (2016) Rui Chen et al. Cell Death & Disease
- Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells
- (2016) Mengling Liu et al. Cell Reports
- Lipid metabolic reprogramming in cancer cells
- (2016) S Beloribi-Djefaflia et al. Oncogenesis
- A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway
- (2014) Min Lu et al. CELL
- ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1
- (2014) Yihua Wang et al. NATURE CELL BIOLOGY
- STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression
- (2014) Casmir Turnquist et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
- (2013) Y Wang et al. CELL DEATH AND DIFFERENTIATION
- Phosphorylation of ASPP2 by RAS/MAPK Pathway Is Critical for Its Full Pro-Apoptotic Function
- (2013) Nadia Godin-Heymann et al. PLoS One
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
- (2012) Teemu J. Murtola et al. PLoS One
- N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence
- (2012) Z. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autophagic activity dictates the cellular response to oncogenic RAS
- (2012) Y. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target
- (2012) Christophe Ginestier et al. STEM CELLS
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
- (2011) Z. Cao et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Effect ofHMGCRVariant Alleles on Low-Density Lipoprotein Cholesterol-Lowering Response to Atorvastatin in Healthy Korean Subjects
- (2011) Jae Yong Chung et al. JOURNAL OF CLINICAL PHARMACOLOGY
- ASPP2 Regulates Epithelial Cell Polarity through the PAR Complex
- (2010) Weili Cong et al. CURRENT BIOLOGY
- ASPP2 Binds Par-3 and Controls the Polarity and Proliferation of Neural Progenitors during CNS Development
- (2010) Roberta Sottocornola et al. DEVELOPMENTAL CELL
- Rb Regulates DNA Damage Response and Cellular Senescence through E2F-Dependent Suppression of N-Ras Isoprenylation
- (2009) Awad Shamma et al. CANCER CELL
- Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma
- (2009) Jian Zhao et al. HEPATOLOGY
- EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma
- (2009) Benoit Terris et al. JOURNAL OF HEPATOLOGY
- Statins in tumor suppression
- (2008) Antonella Sassano et al. CANCER LETTERS
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started